Author:
Kalman D,Incledon T,Gaunaurd I,Schwartz H,Krieger D
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference17 articles.
1. Haller CA, Benowitz NL . Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedrine alkaloids New Engl J Med 2000 242: 1833–1838.
2. Schaefer DC, Cheskin LJ . Update on obesity treatment Gastroenterologist 1998 6: 136–145.
3. National Institute of Health, National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults US Department of Health and Human Services, Public Health Services: Washington, DC 1998.
4. Astrup A, Madsen J, Holst JJ, Christensen NJ . The effect of chronic ephedrine treatment on substrate utilization, the sympathoadrenal activity, and energy expenditure during glucose induced thermogenesis in man Metabolism 1986 35: 260–265.
5. Jacob LS . Drugs affecting peripheral neurohumoral transmission: sympathomimetic agents In Pharmacology 4th Edn Williams & Wilkins: Baltimore, MD 1996 p 28.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献